代表性成果
1、Jain PP#, Lai N#, Xiong M, Chen J, Babicheva A, Zhao T, Parmisano S, Zhao M, Paquin C, Matti M, Powers R, Balistrieri A, Kim NH, Valdez-Jasso D, Thistlethwaite PA, Shyy JY, Wang J, Garcia JGN, Makino A, Yuan JX*. TRPC6, a Therapeutic Target for Pulmonary Hypertension. Am J Physiol Lung Cell Mol Physiol. 2021 Oct 27. doi: 10.1152/ajplung.00159.2021. Online ahead of print.
2、Pritesh P. Jain, Tengteng Zhao, Mingmei Xiong, Shanshan Song, Ning Lai, Shane G. Carr, Aleksandra Babicheva, Marisela Rodriguez, Shamin Rahimi, Francesca Balistrieri, Tatum Simonson, Daniela Valdez-Jasso, Patricia A. Thistlethwaite, John Y.-J. Shyy, Jian Wang, Ayako Makino and Jason X.-J. Yuan. Halofuginone, a Promising Drug for Treatment of Pulmonary Hypertension, Br J Pharmacol. 2021 Mar 10. doi: 10.1111/bph.15442.
3、Xiong M, Jain PP, Chen J, Babicheva A, Zhao T, Alotaibi M, Kim NH, Lai N, Izadi A, Rodriguez M, Li J, Balistrieri A, Balistrieri F, Parmisano S, Sun X, Voldez-Jasso D, Shyy JY, Thistlethwaite PA, Wang J, Makino A, Yuan JX. Mouse model of experimental pulmonary hypertension: Lung angiogram and right heart catheterization. Pulm Circ. 2021 Sep 8;11(4):20458940211041512.
4、Zhang Q, Tsuji-Hosokawa A, Willson C, Watanabe M, Si R, Lai N, Wang Z, Yuan JX, Wang J, Makino A. Chloroquine differentially modulates coronary vasodilation in control and diabetic mice. Br J Pharmacol. 2020 Jan;177(2):314-327.
5、Si R, Zhang Q, Tsuji-Hosokawa A, Watanabe M, Willson C, Lai N, Wang J, Dai A, Scott BT, Dillmann WH, Yuan JX, Makino A. Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes. Cardiovasc Res. 2020 May 1;116(6):1186-1198.
赖克方
